Extracorporeal shock wave treatment (ESWT) for musculoskeletal indications.
D054598:Blue Cross Blue Shield Insurance Plans; D002986:Clinical Trials as Topic; D004599:Electric Stimulation Therapy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D005208:Fasciitis / Q000628:therapy; D006801:Humans; D019458:Insurance Coverage; D009140:Musculoskeletal Diseases / Q000150:complications / Q000628:therapy*; D010148:Intractable Pain / Q000209:etiology / Q000628:therapy*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014464:Ultrasonic Therapy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration